Edaravone ameliorates oxidative damage associated with Aβ25-35 treatment in PC12 cells

Journal of Molecular Neuroscience

Volumn 50, Issue 3, 2013, Pages 494-503

  Zhang, Gui Lian ^a   Zhang, Wang Gang ^a   Du, Yun ^a   Yao, Li ^a   Sun, Hong ^a   Zhang, Ru ^a   Liu, Enqi ^a   Bu, Ning ^a   Wu, Hai Qin ^a   Zhang, Lei ^a   Li, Ting Ting ^a   Guo, Ying Ying ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

A 25 35; Alzheimer's disease; Amyloid beta; Edaravone; MCl 186; Oxidative damage; PC12 cells

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GLUTATHIONE; LACTATE DEHYDROGENASE; LIPID; MALONALDEHYDE; NORPHENAZONE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; OXIDATIVE STRESS; PROTEIN AGGREGATION;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIPYRINE; APOPTOSIS; CELL SURVIVAL; FREE RADICAL SCAVENGERS; GLUTATHIONE; LIPID PEROXIDATION; MALONDIALDEHYDE; MITOCHONDRIA; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84878937019     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-9973-z     Document Type: Article

References (30)

1. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 25:335-358
2. Boothby LA, Doering PL (2005) Vitamin C and vitamin E for Alzheimer's disease. Ann Pharmacother 39:2073-2080
3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3:186-191
4. Chang Z, Luo Y, Zhang Y, Wei G (2011) Interactions of Abeta25-35 beta-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: an all-atom molecular dynamics study. J Phys Chem B 115:1165-1174
5. Chen H, Wang S, Ding JH, Hu G (2008) Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway. J Neurochem 106:2345-2352
6. Dong H, Mao S, Wei J et al (2012) Tanshinone IIA protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Mol Biol Rep 39:6495-6503
7. Fan J, Zhang N, Yin G et al (2012) Edaravone protects cortical neurons from apoptosis by inhibiting the translocation of BAX and increasing the interaction between 14-3-3 and p-BAD. Int J Neurosci 122(11):665-674. doi: 10.3109/00207454.2012.707714
8. Galante D, Corsaro A, Florio T et al (2012) Differential toxicity, conformation and morphology of typical initial aggregation states of Abeta1-42 and Abetapy3-42 beta-amyloids. Int J Biochem Cell Biol 44:2085-2093
9. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204-1222
10. Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA (2010) Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp Neurol 221:26-37
11. Lee HP, Zhu X, Casadesus G et al (2010) Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother 10:1201-1208
12. Maier CM, Chan PH (2002) Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8:323-334
13. Mangialasche F, Polidori MC, Monastero R et al (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8:285-305
14. Martínez E, Navarro A, Ordóñez C, Del Valle E, Tolivia J (2012) Amyloid-beta25-35 induces apolipoprotein D synthesis and growth arrest in HT22 hippocampal cells. J Alzheimers Dis 30:233-244
15. Mattson MP (2006) Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal 8:1997-2006
16. Millucci L, Ghezzi L, Bernardini G, Santucci A (2010) Conformations and biological activities of amyloid beta peptide 25-35. Curr Protein Pept Sci 11:54-67
17. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629-656
18. Pike CJ, Overman MJ, Cotman CW (1995) Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem 270:23895-23898
19. Reddy PH (2006) Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96:1-13
20. Reddy PH (2007) Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid Redox Signal 9:1647-1658
21. Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10-S17
22. Shibata K, Hashimoto T, Nobe K, Hasumi K, Honda K (2011) Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice. Naunyn Schmiedeberg's Arch Pharmacol 384:103-108
23. Song Y, Li M, Li JC, Wei EQ (2006) Edaravone protects PC12 cells from ischemic-like injury via attenuating the damage to mitochondria. J Zhejiang Univ Sci B 7:749-756
24. Uzun S, Kozumplik O, Folnegović-Smalc V (2011) Alzheimer's dementia: current data review. Coll Antropol 35:1333-1337
25. Wang GH, Jiang ZL, Li YC et al (2011) Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats. J Neurotrauma 28:2123-2134
26. Xiong N, Xiong J, Khare G et al (2011) Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. PLoS One 6:e20677
27. Yamamura M, Miyamoto Y, Mitsuno M et al (2010) Edaravone reduces mitochondrial damage due to reperfusion injury following leg ischemia in rats. Int J Angiol 19:e129-e131
28. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N (2006) Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12:9-20
29. Yu M, Li S, Leng W, Chen H, Wu Y, Yan L (2010) Protective effects of MCl-186 on oxidative damage in a cell model of Alzheimer's disease. Neural Regen Res 5:1226-1230
30. Zhou Y, Li W, Xu L, Chen L (2011) In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid beta-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors. Environ Toxicol Pharmacol 31:443-452